Overview

Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Testosterone may lessen weight loss and improve muscle size and strength in patients with cachexia caused by cancer. PURPOSE: This randomized phase I trial is studying whether testosterone administered during standard of care chemotherapy and/or radiation works by helping patients with squamous cell carcinoma to maintain their body weight and muscle size and strength during treatment.
Phase:
Phase 1
Details
Lead Sponsor:
The University of Texas Medical Branch, Galveston
Collaborator:
National Cancer Institute (NCI)
Treatments:
Antineoplastic Agents
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate